Categories AlphaGraphs, Earnings, Technology
Broadcom delivers mixed Q2 results; slashes FY19 revenue outlook
Broadcom (Nasdaq: AVGO) surpassed Q2 earnings estimates, while it missed on revenue targets. Shares of Broadcom slumped about 7% in the after-hours as the company cut down its revenue outlook for FY19. The company reported non-GAAP earnings of $5.21 per share on revenue of $5.52 billion for the second quarter of 2019. Analysts had expected the semiconductor maker to earn $5.18 per share on revenue of $5.69 billion.
On a GAAP basis, the San Jose, California-based firm reported earnings of $1.64 per share compared to earnings of $8.33 per share in the prior-year quarter.
For the fiscal year 2019, Broadcom cut down its revenue outlook to $22.5 billion from the prior outlook of $24.5 billion.
“We currently see a broad-based slowdown in the demand environment, which we believe is driven by continued geopolitical uncertainties, as well as the effects of export restrictions on one of our largest customers. As a result, our customers are actively reducing their inventory levels, and we are taking a conservative stance for the rest of the year,” said CEO Hock Tan.
Also Read: Global semiconductor revenues to fall this year on supply glut, China weakness
Among the peers, Analog Devices (ADI) last month reported lower earnings and revenues for its most recent quarter, hurt by muted demand in the consumer and industrial segments. Earnings decreased year-over-year to $1.36 per share on revenues of $1.53 billion. Earlier, Intel (INTC) posted flat revenues and higher earnings for the first quarter. Revenues matched the market estimates, while earnings beat.
Broadcom stock, which ended up 0.67% at $281.61 today, had advanced 11% since the beginning of 2019 and 7% in the past 52 weeks.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company